# Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

> **NCT06684509** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 46 (estimated)

## Conditions studied

- Leukemia
- Hodgkin Disease

## Interventions

- **DRUG:** Atrovastain

## Key facts

- **NCT ID:** NCT06684509
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2027-09
- **Final completion:** 2029-09
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684509, "Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06684509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*